Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
3.91B | 3.94B | 3.78B | 3.61B | 2.91B | 2.61B | Gross Profit |
1.54B | 1.59B | 1.31B | 1.31B | 1.05B | 933.70M | EBIT |
677.80M | 767.40M | 741.40M | 682.60M | 472.80M | 488.10M | EBITDA |
903.93M | 976.07M | 934.24M | 844.20M | 594.80M | 473.69M | Net Income Common Stockholders |
436.00M | 510.20M | 512.00M | 459.10M | 262.80M | 241.50M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
539.10M | 365.00M | 113.00M | 125.00M | 208.50M | 207.40M | Total Assets |
4.91B | 4.91B | 4.48B | 4.24B | 4.09B | 4.03B | Total Debt |
1.19B | 1.20B | 1.14B | 955.50M | 922.60M | 1.41B | Net Debt |
649.00M | 836.00M | 1.03B | 830.50M | 714.10M | 1.27B | Total Liabilities |
2.81B | 3.05B | 2.87B | 2.91B | 3.03B | 2.99B | Stockholders Equity |
2.10B | 1.86B | 1.61B | 1.33B | 1.06B | 1.04B |
Cash Flow | Free Cash Flow | ||||
361.75M | 464.90M | 7.80M | 497.50M | 666.70M | 247.90M | Operating Cash Flow |
815.73M | 914.20M | 607.60M | 757.20M | 786.90M | 451.20M | Investing Cash Flow |
-467.27M | -470.50M | -660.10M | -348.20M | -120.40M | -203.80M | Financing Cash Flow |
-240.83M | -210.10M | -25.40M | -449.60M | -540.20M | -179.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £65.38B | 20.47 | 15.72% | 1.55% | 2.11% | 3.37% | |
78 Outperform | $36.11B | 38.75 | 12.10% | 0.69% | -2.24% | 3.00% | |
76 Outperform | $7.22B | 16.02 | 33.52% | 0.47% | 0.64% | -1.15% | |
75 Outperform | $33.98B | 32.41 | 11.88% | 0.56% | -0.54% | -48.61% | |
73 Outperform | $10.58B | 7.28 | 6.58% | 1.18% | -8.41% | 570.14% | |
68 Neutral | $10.64B | 24.43 | 21.05% | ― | 1.26% | -17.38% | |
50 Neutral | $1.98B | -1.07 | -21.34% | 3.71% | 2.03% | -30.65% |